Description
A selective PPARα agonist (EC50 = 20 µM) that has been shown to lower adipose tissue weight and reduce plasma insulin concentrations in obese rats and has been used clinically in the treatment of dyslipidemia
Formal name: 2-[4-(2,2-dichlorocyclopropyl)phenoxy]-2-methyl-propanoic acid
Synonyms: (±)-Ciprofibrate|WIN 35,833
Molecular weight: 289.2
CAS: 52214-84-3
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Receptor Pharmacology|Agonists||Research Area|Cardiovascular System|Lipids & Lipoproteins|Lipoproteins||Research Area|Cardiovascular System|Lipids & Lipoproteins|Storage & Transport||Research Area|Endocrinology & Metabolism|Hormones & Receptors|PPARs||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Obesity